Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.56 CAD | -1.16% | -0.39% | +48.84% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 15 | Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral | MT |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 61% by 2026.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+48.84% | 195M | C | ||
+47.74% | 275M | - | ||
+30.93% | 274M | - | ||
-14.29% | 145M | - | - | |
+57.96% | 142M | - | ||
-31.21% | 141M | C | ||
+147.89% | 140M | - | - | |
-7.69% | 80.05M | - | - | |
+150.00% | 75.33M | - | - | |
+43.75% | 66.15M | - | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OGI Stock
- Ratings Organigram Holdings Inc.